학술논문
Antisense Therapeutics for Tumor Treatment: The TGF-beta2 Inhibitor AP 12009 in Clinical Development Against Malignant Tumors.
Document Type
Book Chapter
Author
Source
Pancreatic Cancer (978-3-540-71266-4); 2008, p137-150, 14p
Subject
Language
Abstract
Copyright of Pancreatic Cancer (978-3-540-71266-4) is the property of Springer eBooks and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)